Latest filing published 07 Apr 2026 for ALNYLAM PHARMACEUTICALS, INC., €62k. Read the official filing
All filings by Melissa McLaughlin on record concern Alnylam Pharmaceuticals, Inc. In total, 14 filings cover trades dated from 2 April 2026 to 6 April 2026.
No open-market purchase appears, only 14 sales worth €1.1M.
On 7 April 2026 came the latest disclosure, an open-market sale for €62k in Alnylam Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 5 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations